New Technology– category –
-
New Technology
NIST Advances Nine Digital Signature Algorithms to Third Round of Post-Quantum Cryptography Standardization
Quantum XChange USA Overview The U.S. National Institute of Standards and Technology (NIST) has moved nine digital signature algorithms into a third evaluation round for its post-quantum cryptography (PQC) standardization process. This t... -
New Technology
Lonza Unveils Enhanced DNA-to-IND Biologics Manufacturing Offering with 6-Month Timelines, Introducing GS Ori-Go™
PharmaSource Switzerland Overview Lonza has announced an enhanced 'DNA-to-IND' offering for biologics, aiming to achieve IND-readiness for monoclonal antibody programs in as little as six months. This accelerated timeline is supported by... -
New Technology
SelectScience Hosts Webinar on Microbial Ecosystem Response to Nutrient Changes, Featuring BioXplorer Platform
SelectScience UK Overview SelectScience will host a webinar titled 'Microbes in Motion Exploring Ecosystem Response to Nutrient Changes'. The BioXplorer platform offers automated environmental control, flexible feeding strategies, and in... -
New Technology
Université Laval Announces Research Project on Predictive Modeling for Biomanufacturing Processes
Université Laval Canada Overview Université Laval has announced a research project focused on predictive modeling of biomanufacturing processes. Key themes include digital twins, machine learning, cell culture, proteins, bioreactors, and... -
New Technology
Bioreactor Turndown Ratios in High-Density Perfusion Systems Revolutionize N-1 Perfusion Programs
Drug Discovery News USA Overview Optimizing bioreactor turndown ratios in high-density perfusion systems is revolutionizing N-1 perfusion programs. Bioreactors with turndown ratios of 10:1 or more enable both seed and production cultures... -
New Technology
Biosero Unveils Self-Correcting Bioprocessing Platform to Accelerate Pharma R&D Automation
Biosero USA Overview Biosero has introduced a self-correcting platform advancing bioprocessing automation in pharmaceutical R&D. Future systems are projected to adapt protocols in real-time based on process analytical data, learning ... -
New Technology
STEMCELL Technologies Launches Human iPSC-Derived Hepatic Organoids, Advancing Liver Research
STEMCELL Technologies Canada Overview STEMCELL Technologies has launched human iPSC-derived hepatic organoid products to advance research into liver development, drug-induced liver injury, hepatotoxicity, and metabolism. These organoids ... -
New Technology
Laboratories Accelerate Shift to Automated Adherent and Suspension Cell Culture Platforms with CellXpress.ai Supporting Diverse Cell Types
News-Medical.Net UK Overview Laboratories are rapidly transitioning to automated adherent and suspension cell culture platforms like the CellXpress.ai system. This platform supports diverse cell types including 2D adherent, suspension, a... -
New Technology
Bioprocessing’s ‘AI’ Demystified: Machine Learning Integrates with Existing Tech, Emphasizing Real-time Data at 2026 Summit
Mewburn Ellis UK Overview Discussions at the 2026 Global Bioprocessing & Biotechnology Summit clarified that 'AI' in bioprocessing refers not to large language models, but to the integration of machine learning into existing modeling... -
New Technology
CellXpress.ai System Automates Brain Organoid Generation from iPSCs, Boosting Reproducibility and Efficiency for Neuroscience Research
News-Medical.Net UK Overview The CellXpress.ai automated cell culture system has been developed for the automated generation of brain organoids from iPSCs. Integrating liquid handlers, incubators, imagers, and machine learning-assisted i...